PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 2020

Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation.

Rat / Ischaemia-reperfusion

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 31999976 ↗2020Reported benefit

Scutellarin protects against myocardial ischemia-reperfusion injury by suppressing NLRP3 inflammasome activation.

RatIschaemia-reperfusionCardiacSprague-DawleyMaleIntraperitoneal15 min before vascular ligation

Model: Myocardial ischaemia-reperfusion injury produced by 30 min of coronary ischaemia followed by 24 h of reperfusion; parallel in vitro anoxia/reoxygenation in H9c2 cardiomyoblasts

Scutellarin improved diastolic dysfunction, reduced myocardial structural abnormality, inhibited myocyte apoptosis and inflammation and promoted autophagy. It reduced NLRP3 inflammasome activation, inhibited mTORC1 and increased Akt phosphorylation, and the protective effect was abolished by siRNA…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.7. Machine-extracted fields require source verification.